about
Role of ROS and RNS Sources in Physiological and Pathological ConditionsYME1L degradation reduces mitochondrial proteolytic capacity during oxidative stressFailure of hyperglycemia and hyperinsulinemia to compensate for impaired metabolic response to an oral glucose load.Tryptamine-gallic acid hybrid prevents non-steroidal anti-inflammatory drug-induced gastropathy: correction of mitochondrial dysfunction and inhibition of apoptosis in gastric mucosal cells.Genetic ablation of lymphocytes and cytokine signaling in nonobese diabetic mice prevents diet-induced obesity and insulin resistanceProtective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications.Mitochondrial function in ageing: coordination with signalling and transcriptional pathways.Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies.Distinct effects of oleic acid and its trans-isomer elaidic acid on the expression of myokines and adipokines in cell models.Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury.Qigong Exercises for the Management of Type 2 Diabetes Mellitus.Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55.Effects of 12 Months of Caloric Restriction on Muscle Mitochondrial Function in Healthy Individuals.A polygenic score for schizophrenia predicts glycemic control.Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule.Dodecanedioic acid overcomes metabolic inflexibility in type 2 diabetic subjects.
P2860
Q26740342-459FFAE2-EEC9-44A6-A968-48CD586008CDQ28252350-AB7F8A63-78AF-4636-99D5-CBA68CAD48CEQ35097041-FEBC12C9-C30A-48AC-AE98-A357B68A73DDQ35728510-C1CF753C-98FA-45C2-BC15-D46DC1D86D88Q36570968-C4F63FC0-178A-4E3C-BCB7-A1876C321371Q37494299-7CA9188A-4D45-450F-9B2C-09071137DDC5Q38570535-F5FD41CF-3A70-42D2-B3B6-DDF059C69C72Q39005762-466DF151-E26C-4F42-8074-C66F0ADE0B60Q39611891-A32F35ED-A8F5-4475-8FBE-246D2018C9D2Q41129927-45A41AAA-CCFA-4FCE-A763-8E1FE97BC0EEQ41903375-6CFA3EDC-E6D5-4636-B280-EDF882AA379EQ42450828-A40F791A-4BDA-4FF8-9041-D4A3F9F75470Q43747230-486E562D-84BD-4A0F-84F1-6734BC353CF6Q47294911-EB05BFC5-F3C7-4E93-AE3A-60714780B886Q51776565-CC6A1C75-A47C-4CF4-BC67-11BB291D28B2Q51939433-0A1CBE46-0E43-45FE-9584-7AA283BF4694
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Mitochondrial dysfunction and type 2 diabetes.
@ast
Mitochondrial dysfunction and type 2 diabetes.
@en
Mitochondrial dysfunction and type 2 diabetes.
@nl
type
label
Mitochondrial dysfunction and type 2 diabetes.
@ast
Mitochondrial dysfunction and type 2 diabetes.
@en
Mitochondrial dysfunction and type 2 diabetes.
@nl
prefLabel
Mitochondrial dysfunction and type 2 diabetes.
@ast
Mitochondrial dysfunction and type 2 diabetes.
@en
Mitochondrial dysfunction and type 2 diabetes.
@nl
P2860
P1476
Mitochondrial dysfunction and type 2 diabetes.
@en
P2093
Rebecca Parish
P2860
P2888
P304
P356
10.1007/S11892-005-0006-3
P577
2005-06-01T00:00:00Z
P5875
P6179
1018285450